Kwang Dong Pharmaceutical Co., Ltd. (009290.KS) KSC

Currency In KRW

AD

Valuation

Market Cap307.19B
Enterprise Value469.4B
P/E Ratio11.75
PEG Ratio-0.56
Price/Sales Ratio0.18
Price/Book Ratio0.46
Enterprise/Revenue0.3
Enterprise/EBITDA9.34

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.01
Operating Margin0.02
AD

Management Effectiveness

Return On Assets0.02
Return On Equity0.03

Income Statement

Revenue1.66T
Revenue/Share34,086.35
Gross Profit293.22B
EBITDA48.54B
Net Income20.97B
Diluted EPS521

Balance Sheet

Total Cash182.71B
Total Cash/Share3,679.1
Total Debt301.19B
Total Debt/Equity0.47
Current Ratio1.3
Book Value Per Share14,404.1

Price History

52-Week Change1.34
52-Week High12,800
52-Week Low5,150
Moving Average 50 Days6,159.6
Moving Average 200 Days6,793.6

Statistics

Average Volume217,144
Shares Outstanding49.66M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate100
Trailing Annual Dividend Yield1.65
Payout Ratio0.18
Last Split FactorN/A
Last Split DateN/A
AD